A Phase IV open-label study to evaluate the safety and efficacy of 1mg/kg SQ administered efaluzimab in adults with bullous pemphigoid as a steroid sparing adjunctive treatment
(PI: Chen) Drug Support Only
Awarded By
- Genentech
Contributors
- Chen, Suephy C Prinicipal Investigator
Start/End
- 2006 - December 2007